Ambitious and accomplished engineering leader with over 25 years of experience in driving operational excellence and strategic initiatives within matrix and multicultural environments in the pharmaceutical industry. Proven expertise in leading global teams, optimizing asset, and delivering projects.

Certified in Advanced Asset Management, with a focus on Continuous Improvement, Engineering, Performance, Digitalization and Compliance. Adept at fostering innovation, enhancing productivity, and creating significant business value through strategic execution and delivery.

The Pop in Your Job: In my role at GSK, I deliver innovative smart engineering solutions across various sites, focusing on enhancing asset uptime, equipment reliability, maintenance effectiveness, manufacturing capacity, and overall productivity. What drives me is the opportunity to collaborate with diverse teams, making their daily tasks easier and more efficient. I am passionate about the impact of new technologies on improving people's work experiences. The connection with sites worldwide allows me to embrace different cultures and address unique needs. Working for GSK, a company dedicated to bettering and improving human health, aligns with my values and commitment to contributing to a healthier world.

GSK is a global biopharma company with a mission to unite science, technology, and talent to get ahead of disease together. Our goal is to positively impact the health of 2.5 billion people by the end of the decade, fostering a thriving environment for our team. As a focused biopharma company, we specialize in preventing and treating diseases through specialty medicines, vaccines, and general medicines. Our research concentrates on the science of the immune system and advanced technologies, with significant investments in respiratory, immunology and inflammation, oncology, HIV, and infectious diseases. Our Ahead Together strategy emphasizes early intervention to prevent and change the course of diseases, supporting people and healthcare systems. We aim to discover new, better medicines and vaccines while also preventing illnesses and mitigating their long-term impacts. Our robust portfolio and pipeline continue to grow, with key milestones achieved across our core therapeutic areas in 2023. Strategic partnerships, such as those with the University of Oxford on neurodegenerative diseases, Kings College London on cancer treatment, and 23andMe on genetics and genomics, are vital to our discovery efforts. Our culture at GSK is driven by a commitment to being ambitious for patients, accountable for impact, and doing the right thing, ensuring that GSK remains an exciting and inspiring place to work. Our Code outlines the commitments we uphold to achieve our goals and bring our culture to life, making GSK a place where people can thrive.